These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 5090680

  • 1. Influenza virus infection in mice: the effect of avirulent virus infection on the pathogenicity of highly virulent virus.
    Kurimura T, Hirano A, Suzuki N, Okuno Y.
    Biken J; 1971 Mar; 14(1):65-73. PubMed ID: 5090680
    [No Abstract] [Full Text] [Related]

  • 2. The nature of the immunity evoked by infection of mice with avirulent influenza virus.
    Kurimura T, Hirano A, Okuno Y.
    Biken J; 1972 Mar; 15(1):31-7. PubMed ID: 5055346
    [No Abstract] [Full Text] [Related]

  • 3. A-Turkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus.
    Beard CW, Easterday BC.
    Avian Dis; 1973 Mar; 17(1):173-81. PubMed ID: 4697709
    [No Abstract] [Full Text] [Related]

  • 4. [Studies with the influenza virus strain A2 Moscow 57-65].
    Herzberg K, Reuss K.
    Zentralbl Bakteriol Orig; 1968 Mar; 206(2):139-49. PubMed ID: 5707653
    [No Abstract] [Full Text] [Related]

  • 5. [Immunity tests with a Hong Kong strain influenza virus lethal to mice].
    Herzberg K.
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):298-303. PubMed ID: 5456375
    [No Abstract] [Full Text] [Related]

  • 6. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain.
    Sidorova LA, Alekseyeva AK.
    Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209
    [No Abstract] [Full Text] [Related]

  • 7. Humoral and cell-mediated immune response to influenza virus. I. Experiments in mice.
    Semkow R, Loza-Tulimowska M, Wilczyński J, Brydak L, Zgorzelska K.
    Acta Microbiol Pol; 1982 Jul; 31(2):185-94. PubMed ID: 6188341
    [No Abstract] [Full Text] [Related]

  • 8. Immunity to influenza in ferrets. I. Response to live and killed virus.
    Potter CW, Oxford JS, Shore SL, McLaren C, Stuart-Harris C.
    Br J Exp Pathol; 1972 Apr; 53(2):153-67. PubMed ID: 5032092
    [Abstract] [Full Text] [Related]

  • 9. Humoral and cell-mediated immune response to influenza virus. II. Experiments in ferrets.
    Semkow R, Loza-Tulimowska M, Brydak L, Zgorzelska K, Wilczyński J, Sadowski W.
    Acta Microbiol Pol; 1982 Apr; 31(2):195-202. PubMed ID: 6188342
    [No Abstract] [Full Text] [Related]

  • 10. Interferonogenicity and other properties of partially inactivated influenza virus.
    Orlova TG, Yeryomkina EI.
    Acta Virol; 1971 Mar; 15(2):126-32. PubMed ID: 4396411
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model.
    Lipatov AS, Webby RJ, Govorkova EA, Krauss S, Webster RG.
    J Infect Dis; 2005 Apr 15; 191(8):1216-20. PubMed ID: 15776365
    [Abstract] [Full Text] [Related]

  • 12. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K, Haasbach E, Fuchs C, Weinzierl AO, Stevanovic S, Büttner M, Planz O.
    Vaccine; 2008 Dec 09; 26(52):6965-74. PubMed ID: 18848593
    [Abstract] [Full Text] [Related]

  • 13. Immunity to influenza in ferrets. II. Influence of adjuvants on immunization.
    Potter CW, Shore SL, McLaren C, Stuart-Harris C.
    Br J Exp Pathol; 1972 Apr 09; 53(2):168-79. PubMed ID: 4338059
    [Abstract] [Full Text] [Related]

  • 14. Effect of lymphocytosis-promoting factor (LPF) on the appearnace of antibodies in mice infected with influenza virus.
    Iwasaki T, Nozima T.
    J Immunol; 1970 May 09; 104(5):1293-4. PubMed ID: 5444340
    [No Abstract] [Full Text] [Related]

  • 15. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
    Häkkinen I, Halonen P.
    J Natl Cancer Inst; 1971 Jun 09; 46(6):1161-7. PubMed ID: 4325929
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Experimental demonstration of the capacity of the influenza virus persisting in the body to cause a slow infection].
    Zuev VA, Mirchink EP, Kharitonova AM.
    Vestn Akad Med Nauk SSSR; 1985 Jun 09; (3):26-31. PubMed ID: 3993190
    [No Abstract] [Full Text] [Related]

  • 18. [Genetic markers and their variability in influenza viruses isolated from the 1968-1969 influenza epidemic. I. The biologic properties of strains of variety A2 (Hong Kong) 1-68].
    Sokolov MI, Podcherniaeva RIa, Parasiuk NA, Miasnikova IA, Men'shikh LK.
    Vopr Virusol; 1970 Jun 09; 15(6):677-80. PubMed ID: 5518642
    [No Abstract] [Full Text] [Related]

  • 19. Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection.
    Ueda S, Nozima T.
    Acta Virol; 1973 Jan 09; 17(1):41-9. PubMed ID: 4405395
    [No Abstract] [Full Text] [Related]

  • 20. Influence of a thymus polypeptide extract (TP1) on immunogenesis and on experimental influenza infection in x-rayed animals.
    Milcu SM, Potop I, Boeru V, Prahoveanu E, Petrescu A, Teodosiu O.
    Endocrinologie; 1977 Jan 09; 15(3):167-71. PubMed ID: 918526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.